Product Description:

• Product Name: Rifaximin
• Drug Classification: Antibiotic
• Strength: 200 mg and 550 mg
• Product Form: Tablets
• Packing Specifications: 10’s

Pharmacokinetics:

Rifaximin is a broad-spectrum antibiotic with excellent gastrointestinal absorption and minimal systemic absorption. Following oral administration, it is primarily concentrated in the gastrointestinal tract, where it exerts its therapeutic effects.

Pharmacodynamics:

Rifaximin works by inhibiting bacterial RNA synthesis, thereby disrupting bacterial cell growth and replication. It is highly effective against a wide range of gram-positive and gram-negative bacteria, including Escherichia coli and Clostridium difficile.

Formulations:

Rifaximin is available in tablet form, each containing 200 mg of the active ingredient.

Indications:

Rifaximin is indicated for the treatment of various gastrointestinal conditions, including:

• Traveler’s diarrhea
• Irritable bowel syndrome with diarrhea (IBS-D)
• Hepatic encephalopathy

Usage:

Rifaximin should be taken orally with or without food as directed by a healthcare professional. It is important to complete the full course of treatment, even if symptoms improve before the medication is finished.

Dosage:

The recommended dosage of Rifaximin for adults is 200 mg taken orally three times a day for the treatment of traveler’s diarrhea and IBS-D. For hepatic encephalopathy, the recommended dosage is 550 mg taken orally twice daily.

Side Effects:

Common side effects of Rifaximin may include:

• Nausea
• Abdominal pain
• Headache
• Flatulence

Rare but serious side effects may include severe allergic reactions and liver problems. It is important to seek medical attention if any unusual or severe side effects occur.

AIT Pharmaceuticals Division is dedicated to ensuring the safety and efficacy of our products. For further information, please consult your healthcare professional or refer to the product label.